← Leaderboards
Joshua A Salomon
Harvard School Of Public Health
$7,637,171
Attributed
$10,374,760
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2009–23$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$7,524,760 · 6
CDC$2,850,000 · 1
By mechanism
R01$6,818,322 · 3
U38$2,850,000 · 1
P01$604,997 · 2
R03$101,441 · 1
Top collaborators
- Theodore H Cohen8 shared
Most similar at Harvard School Of Public Health
Same institution · by research overlap
- William Hanage$8,230,810
- Caroline O'Flaherty Buckee$4,083,399
- Jennifer M. Yeh$7,047,019
- Molly Forrest Franke$11,435,450
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsCommunitiesCostResourcesMorbidity - Disease RateResearch PersonnelBaseIncidenceRisk FactorsPoliciesCountryPrevalenceDiagnosisAfrica South Of The SaharaAfricaPatternInvestigationDesignAntiretroviral TherapyResearch ActivityPhenotypeHiv InfectionsPolicy MakerMortality Vital Statistics
Grant awards (23)
Integrating genomic and spatial approaches for targeted control of HIV-associated tuberculosis epidemics$649,564
R01 · FY2023 · AI
Integrating genomic and spatial approaches for targeted control of HIV-associated tuberculosis epidemics$768,475
R01 · FY2022 · AI
Integrating genomic and spatial approaches for targeted control of HIV-associated tuberculosis epidemics$779,086
R01 · FY2021 · AI
Multimorbidity$103,353
P01 · FY2021 · AG · contact PI
Integrating genomic and spatial approaches for targeted control of HIV-associated tuberculosis epidemics$870,052
R01 · FY2020 · AI
Multimorbidity$103,353
P01 · FY2020 · AG · contact PI
Multimorbidity$136,505
P01 · FY2019 · AG · contact PI
Multimorbidity$108,711
P01 · FY2018 · AG · contact PI
Evaluating health and economic effects of targeted strategies in TB/HIV$562,005
R01 · FY2017 · AI
Multimorbidity$79,438
P01 · FY2017 · AG · contact PI
Evaluating health and economic effects of targeted strategies in TB/HIV$579,864
R01 · FY2016 · AI
Economic Modeling for HIV, Viral Hepatitis, STD, TB and School Health$1,450,000
U38 · FY2015 · PS · contact PI
Evaluating health and economic effects of targeted strategies in TB/HIV$591,645
R01 · FY2015 · AI
MEASURES AND METHODS$36,258
P01 · FY2015 · AG · contact PI
Economic Modeling for HIV, Viral Hepatitis, STD, TB and School Health$1,400,000
U38 · FY2014 · PS · contact PI
Evaluating health and economic effects of targeted strategies in TB/HIV$674,488
R01 · FY2014 · AI
Reducing disparities in diabetes through expanded insurance coverage.$413,107
R01 · FY2013 · DK · contact PI
MEASURES AND METHODS$37,379
P01 · FY2013 · AG · contact PI
Reducing disparities in diabetes through expanded insurance coverage.$1,500
R01 · FY2013 · DK · contact PI
Reducing disparities in diabetes through expanded insurance coverage.$419,710
R01 · FY2012 · DK · contact PI
Reducing disparities in diabetes through expanded insurance coverage.$508,826
R01 · FY2011 · DK · contact PI
Comparability of self-reports on functional health$33,588
R03 · FY2010 · AG · contact PI
Comparability of self-reports on functional health$67,853
R03 · FY2009 · AG · contact PI